The U.S. Food and Drug Administration (FDA) announced on Thursday, May 5, that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen COVID-19 vaccine to people who are 18 and older due to a risk of TTS.
A preliminary South African government study published Thursday showed a booster of the Johnson & Johnson Covid vaccine was 85 percent effective in preventing hospitalization from the Omicron variant, a finding that helps revive the shot's reputatio
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.